Posts by tag
drug repurposing
Drug repurposing: EU legislative changes could speed up new treatment options
The length of time it takes for each new cancer drug to reach the market – and more importantly, the patient – remains a cause of deep frustration particularly among those whose lives depend on accessing new options. Concrete data…
Drug repurposing approaches offer hope for squamous cell carcinoma and Alzheimer’s disease
Two recent publications highlight the growing interest of drug repurposing in oncology. A study in Cancer Prevention Research (published online 12 April) shows how dopamine can stop the development and progression of ultraviolet B (UVB)-induced precancerous squamous skin cancers; while…
Link between COVID-19 and prostate cancer raises possibility of new treatments
The overlapping biology identified between the molecular pathogenesis of COVID-19 and prostate cancer raises the possibility of repurposing drugs, including androgen deprivation therapy, for treating COVID-19, suggests a review in Nature Communications Biology, published 8 July. In the review the…
Non-cancer drugs repurposing, a new trick to win the onco-challenge?
Originally developed and approved for use in diabetes, inflammation and other non-oncological diseases (even osteoarthritis in dogs), many drugs could have a pivotal role in treating cancer. And they could be more abundant than expected, according to a paper recently…